{"title":"基于99mtc标记的黑色素瘤SPECT/CT成像的CXCR4环肽分子对接创新设计","authors":"Xianrui Yin, Xin Wang, Chengwei Chen, Shenglan Jia, Wanhong Li, Yihong Wu, Xin Chen, Danling Feng, Wai Ping Cecilia Tsang, Zhihao Han, Yueqing Gu","doi":"10.1016/j.aca.2025.344754","DOIUrl":null,"url":null,"abstract":"<h3>Backgroud</h3>The chemokine receptor CXCR4 is a crucial target for the diagnosis and treatment of cancer due to its close association with tumor growth, metastasis, invasiveness, and prognosis.<h3>Results</h3>The cyclic peptides KC1 and KC1E, along with their radiolabeled conjugates [<sup>99m</sup>Tc]Tc-HYNIC-KC1 and [<sup>99m</sup>Tc]Tc-HYNIC-KC1E, were successfully synthesized. The binding affinity of KC1 toward the CXCR4 receptor was evaluated using Surface Plasmon Resonance (SPR). Furthermore, key physicochemical and biological properties of the radiotracers were systematically assessed, including the oil-water partition coefficient (LogP), in vitro stability in normal saline solution and mouse serum, in vivo SPECT/CT imaging performance in a B16-F10 tumor-bearing mouse model, and biodistribution profiles following intravenous administration.<h3>Significance</h3>A novel cyclic peptide, KC1, was designed and shown to exhibit selective binding to the CXCR4 receptor. Molecular docking simulations were performed to elucidate the potential interaction mechanism between KC1 and CXCR4. The radiolabeled derivative [<sup>99m</sup>Tc]Tc-HYNIC-KC1E was synthesized and demonstrated favorable in vivo imaging performance in B16-F10 tumor-bearing mice, supporting its potential as a promising imaging agent for CXCR4-positive tumors.","PeriodicalId":240,"journal":{"name":"Analytica Chimica Acta","volume":"29 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Innovative Design of CXCR4 Cyclic Peptide via Molecular Docking for 99mTc-Labeled SPECT/CT Imaging in Melanoma\",\"authors\":\"Xianrui Yin, Xin Wang, Chengwei Chen, Shenglan Jia, Wanhong Li, Yihong Wu, Xin Chen, Danling Feng, Wai Ping Cecilia Tsang, Zhihao Han, Yueqing Gu\",\"doi\":\"10.1016/j.aca.2025.344754\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3>Backgroud</h3>The chemokine receptor CXCR4 is a crucial target for the diagnosis and treatment of cancer due to its close association with tumor growth, metastasis, invasiveness, and prognosis.<h3>Results</h3>The cyclic peptides KC1 and KC1E, along with their radiolabeled conjugates [<sup>99m</sup>Tc]Tc-HYNIC-KC1 and [<sup>99m</sup>Tc]Tc-HYNIC-KC1E, were successfully synthesized. The binding affinity of KC1 toward the CXCR4 receptor was evaluated using Surface Plasmon Resonance (SPR). Furthermore, key physicochemical and biological properties of the radiotracers were systematically assessed, including the oil-water partition coefficient (LogP), in vitro stability in normal saline solution and mouse serum, in vivo SPECT/CT imaging performance in a B16-F10 tumor-bearing mouse model, and biodistribution profiles following intravenous administration.<h3>Significance</h3>A novel cyclic peptide, KC1, was designed and shown to exhibit selective binding to the CXCR4 receptor. Molecular docking simulations were performed to elucidate the potential interaction mechanism between KC1 and CXCR4. The radiolabeled derivative [<sup>99m</sup>Tc]Tc-HYNIC-KC1E was synthesized and demonstrated favorable in vivo imaging performance in B16-F10 tumor-bearing mice, supporting its potential as a promising imaging agent for CXCR4-positive tumors.\",\"PeriodicalId\":240,\"journal\":{\"name\":\"Analytica Chimica Acta\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analytica Chimica Acta\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1016/j.aca.2025.344754\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytica Chimica Acta","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1016/j.aca.2025.344754","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
Innovative Design of CXCR4 Cyclic Peptide via Molecular Docking for 99mTc-Labeled SPECT/CT Imaging in Melanoma
Backgroud
The chemokine receptor CXCR4 is a crucial target for the diagnosis and treatment of cancer due to its close association with tumor growth, metastasis, invasiveness, and prognosis.
Results
The cyclic peptides KC1 and KC1E, along with their radiolabeled conjugates [99mTc]Tc-HYNIC-KC1 and [99mTc]Tc-HYNIC-KC1E, were successfully synthesized. The binding affinity of KC1 toward the CXCR4 receptor was evaluated using Surface Plasmon Resonance (SPR). Furthermore, key physicochemical and biological properties of the radiotracers were systematically assessed, including the oil-water partition coefficient (LogP), in vitro stability in normal saline solution and mouse serum, in vivo SPECT/CT imaging performance in a B16-F10 tumor-bearing mouse model, and biodistribution profiles following intravenous administration.
Significance
A novel cyclic peptide, KC1, was designed and shown to exhibit selective binding to the CXCR4 receptor. Molecular docking simulations were performed to elucidate the potential interaction mechanism between KC1 and CXCR4. The radiolabeled derivative [99mTc]Tc-HYNIC-KC1E was synthesized and demonstrated favorable in vivo imaging performance in B16-F10 tumor-bearing mice, supporting its potential as a promising imaging agent for CXCR4-positive tumors.
期刊介绍:
Analytica Chimica Acta has an open access mirror journal Analytica Chimica Acta: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
Analytica Chimica Acta provides a forum for the rapid publication of original research, and critical, comprehensive reviews dealing with all aspects of fundamental and applied modern analytical chemistry. The journal welcomes the submission of research papers which report studies concerning the development of new and significant analytical methodologies. In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and impact of the research and the extent to which it adds to the existing body of knowledge in analytical chemistry.